N-(4-(((2,4-Diaminoquinazolin-6-yl)amino)methyl)phenethyl)benzo[d][1,3]dioxole-5-carboxamide

ID: ALA4207961

Chembl Id: CHEMBL4207961

PubChem CID: 145970741

Max Phase: Preclinical

Molecular Formula: C25H24N6O3

Molecular Weight: 456.51

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1nc(N)c2cc(NCc3ccc(CCNC(=O)c4ccc5c(c4)OCO5)cc3)ccc2n1

Standard InChI:  InChI=1S/C25H24N6O3/c26-23-19-12-18(6-7-20(19)30-25(27)31-23)29-13-16-3-1-15(2-4-16)9-10-28-24(32)17-5-8-21-22(11-17)34-14-33-21/h1-8,11-12,29H,9-10,13-14H2,(H,28,32)(H4,26,27,30,31)

Standard InChI Key:  RZEQSTAYIQIHAS-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4207961

    ---

Associated Targets(non-human)

Cysteine protease falcipain-2 (149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dihydrofolate reductase (1810 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 456.51Molecular Weight (Monoisotopic): 456.1910AlogP: 3.11#Rotatable Bonds: 7
Polar Surface Area: 137.41Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.41CX LogP: 2.95CX LogD: 2.65
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.33Np Likeness Score: -0.98

References

1. Chen W, Huang Z, Wang W, Mao F, Guan L, Tang Y, Jiang H, Li J, Huang J, Jiang L, Zhu J..  (2017)  Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.,  25  (24): [PMID:29111368] [10.1016/j.bmc.2017.10.017]

Source